Pia Björck,Christine Tan,Erin Filbert,Xiaodong Yang
申请号：
US16250779
公开号：
US20190218296A1
申请日:
2019.01.17
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases. Specifically, high affinity, humanized anti-PD-L1 antibodies are provided.
